TCL-1B activators represent a unique and intriguing category within the realm of chemical compounds, primarily associated with their ability to modulate specific cellular processes and signaling pathways. These molecules belong to a class of bioactive substances known for their capacity to interact with TCL-1B proteins, thereby exerting influence over a range of intracellular events. TCL-1B, an abbreviation for T-cell leukemia/lymphoma protein 1B, is a crucial player in the regulation of T-cell development and function. TCL-1B activators, through their distinct chemical structures, possess the capability to stimulate or enhance the activity of TCL-1B, leading to various cellular responses.
TCL-1B activators are characterized by their affinity for TCL-1B proteins, typically binding to specific sites or domains on the protein surface. This interaction triggers a cascade of molecular events, potentially altering the protein's conformation or activity. While the precise mechanisms and structural details of TCL-1B activation by these compounds may vary, they all share the common characteristic of modulating TCL-1B function. Consequently, TCL-1B activators can influence critical cellular processes, such as cell differentiation, proliferation, and survival, which are particularly relevant in the context of immune system regulation. The elucidation of the structural and biochemical properties of TCL-1B activators continues to be an active area of research, as scientists seek to uncover their potential roles in cellular physiology. Understanding these compounds and their effects on TCL-1B may shed light on broader aspects of cell biology and immune system function, offering insights into the intricacies of molecular signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate substrates that may interact with TCL1B, leading to its activation or enhanced function within T-cell signaling or proliferation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP, which activates PKA. PKA then could phosphorylate TCL1B or associated proteins, enhancing TCL1B's role in T-cell activation or B-cell development. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, which might activate calcium-dependent kinases that phosphorylate TCL1B or associated proteins, enhancing TCL1B's function in lymphocyte signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB, potentially leading to altered signaling environments that favor TCL1B activity in processes like cell survival and proliferation. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin activates PKC, which may lead to the phosphorylation and activation of proteins that interact with TCL1B, potentially enhancing TCL1B's functionality in T-cell signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA, which could then phosphorylate TCL1B or associated proteins, indirectly enhancing TCL1B's role in cellular signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation states that could enhance TCL1B activity or stability indirectly. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases such as PP1 and PP2A, potentially enhancing the phosphorylation and activity of TCL1B or proteins that regulate TCL1B function. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 activates PKC, which could lead to the phosphorylation of proteins that interact with TCL1B, potentially enhancing the function of TCL1B in signal transduction. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which may influence TCL1B activity or stability by altering the signaling environment in lymphocytes. | ||||||